Addex Therapeutics Ltd (NASDAQ:ADXN)

Delayed Data
As of Jun 02
 -0.0036 / -0.51%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Addex Therapeutics Ltd have a median target of 1.07, with a high estimate of 1.07 and a low estimate of 1.07. The median estimate represents a +54.38% increase from the last price of 0.70.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Outperform stock in Addex Therapeutics Ltd. This rating has held steady since December, when it was unchanged from a Outperform rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 84.63%
Growthannually 66.88%


Growthquarterly -44.88%
Growthannually 21.68%
Key to the earnings and sales forecast charts.